CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 3.21: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.24%Below 5Y avg (0.51%)
Annual Rate
CNY 0.01Paid annual
Payout Ratio
28.5%Sustainable
Last Ex-Dividend
May 27, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.97BCNY441.71M · vs all stocks (USD)
Trailing P/E
57.00xRevenue (TTM)
747.80MCNY111.06M · vs all stocks (USD)
Profit Margin
7.35%Beta
0.1840xvs all stocks
52-Week Change
-17.33%vs all stocks
Market Capitalization
2.97BCNY441.71M · vs all stocks (USD)
Enterprise Value
3.04BCNY451.16M · vs all stocks (USD)
Trailing P/E
57.00xPrice to Sales (TTM)
4.07xPrice to Book (MRQ)
1.72xEnterprise to Revenue
4.06xEnterprise to EBITDA
19.54xGross Margin
24.29%Profit Margin
7.35%Operating Margin
13.63%Return on Assets (TTM)
1.35%Return on Equity (TTM)
3.18%Revenue (TTM)
747.80MCNY111.06M · vs all stocks (USD)
Revenue per Share (TTM)
1.27CNYUpdated Aug 19, 2026Quarterly Revenue Growth
1.30%Gross Profit (TTM)
157.10MCNY23.33M · vs all stocks (USD)
EBITDA (TTM)
92.13MCNY13.68M · vs all stocks (USD)
Net Income (TTM)
54.99MCNY8.17M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
3.40%Operating Cash Flow (TTM)
164.39MCNY24.42M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
37.37MCNY5.55M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0120CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.24%vs all stocks
5-Year Average Dividend Yield
0.51%vs all stocks
Payout Ratio
28.51%Revenue
745.31MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
571.24MCNYFY2025 · Dec 31, 2025Gross Profit
174.07MCNYFY2025 · Dec 31, 2025Operating Income
79.92MCNY11.87M · vs all stocks (USD)
Pre-tax Income
61.92MCNYFY2025 · Dec 31, 2025Income Tax Expense
7.58MCNYFY2025 · Dec 31, 2025Net Income
54.34MCNYFY2025 · Dec 31, 2025EBIT
65.93MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
179.57MCNYFY2025 · Dec 31, 2025Research & Development
25.48MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
17.64MCNYFY2025 · Dec 31, 2025Other Operating Expenses
12.32MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
2.78MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
4.01MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.0928CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.0868CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
585.53MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
585.53MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
54.34MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
1.90KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
70.21MCNYFY2025 · Dec 31, 2025Free Cash Flow
-8.91MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
458.77MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
54.34MCNYFY2025 · Dec 31, 2025Other Non-cash Items
3.91MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
71.76MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-59.79MCNYFY2025 · Dec 31, 2025Capital Expenditures
-79.12MCNYFY2025 · Dec 31, 2025Other Investing Activity
5.88MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-73.24MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
54.40MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-52.10MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-18.28MCNYFY2025 · Dec 31, 2025Other Financing Charges
-56.00MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-71.98MCNYFY2025 · Dec 31, 2025Shares Outstanding
593.61MSharesUpdated Aug 19, 2026Float Shares
382.31MSharesUpdated Aug 19, 2026% Held by Insiders
31.05%vs all stocks
% Held by Institutions
5.40%vs all stocks
Total Cash (MRQ)
458.68MCNY68.12M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.7870CNYUpdated Aug 19, 2026Total Debt (MRQ)
505.45MCNY75.07M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2900xCurrent Ratio (MRQ)
4.81xBook Value per Share (MRQ)
2.99CNYUpdated Aug 19, 2026Total Assets
2.55BCNY378.68M · vs all stocks (USD)
Total Current Assets
1.15BCNYFY2025 · Dec 31, 2025Total Liabilities
826.49MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.40BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
590.64MCNYFY2025 · Dec 31, 2025Total Current Liabilities
235.85MCNYFY2025 · Dec 31, 2025Cash
458.77MCNYFY2025 · Dec 31, 2025Cash Equivalents
23.61MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
482.38MCNYFY2025 · Dec 31, 2025Accounts Receivable
180.62MCNYFY2025 · Dec 31, 2025Inventory
401.37MCNYFY2025 · Dec 31, 2025Accounts Payable
152.18MCNYFY2025 · Dec 31, 2025Short-term Debt
6.49MCNYFY2025 · Dec 31, 2025Other Current Liabilities
38.15MCNYFY2025 · Dec 31, 2025Long-term Debt
493.70MCNYFY2025 · Dec 31, 2025Common Stock (Book)
593.61MCNYFY2025 · Dec 31, 2025Retained Earnings
448.91MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.72BCNY255.93M · vs all stocks (USD)
Treasury Stock
56.11MCNYFY2025 · Dec 31, 202552-Week Low
4.46CNYUpdated Aug 19, 202652-Week High
6.82CNYUpdated Aug 19, 202652-Week Change
-17.33%vs all stocks
Beta
0.1840xvs all stocks
50-Day MA
5.04CNYUpdated Aug 19, 2026200-Day MA
5.56CNYUpdated Aug 19, 2026Avg 10-Day Volume
7.42MSharesUpdated Aug 19, 2026Avg 30-Day Volume
10.40MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.0900CNYUpdated Aug 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.21: safe zoneNotable
Altman Z-Score: 3.21
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Delcath Systems Inc.
Tier 1ProductionApproval-Gated PipelineRule
Jiangxi Synergy Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Clover Biopharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hubei Goto Biopharm Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Rezolute, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Benitec Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Varex Imaging Corporation
Tier 1ProductionApproval-Gated PipelineRule
Shoulder Innovations, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Jw Pharmaceutical Corporation
Tier 1ProductionApproval-Gated PipelineRuleFlow
Avacta Group Plc
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking